#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	2960	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2555	341.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1647	1647	C	386	C,A,T	330,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4540	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3849	351.9	0	.	n	.	0	T695C	SNP	695	695	T	1161	1161	C	392	C,T,A	332,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4540	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3849	351.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1803	1803	A	401	A	349	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4540	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3849	351.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2437	2437	C	409	C	349	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4540	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3849	351.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3063	3063	T	352	T,G	294,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4540	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3849	351.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2511	2511	A	393	A	339	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	V36A	NONSYN	106	108	GTG	602	604	GCG	57;57;58	G;C;G	51;52;52	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	644	646	CGG	54;55;55	C,A;G;G	46,1;49;50	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	S68L	NONSYN	202	204	TCG	698	700	TTG	61;62;62	T;T;G	51;48;53	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	A90V	NONSYN	268	270	GCG	764	766	GTT	56;56;57	G;T;T	48;48;49	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	I105V	NONSYN	313	315	ATT	809	811	GTT	55;55;55	G;T;T	46;40;43	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	N125T	NONSYN	373	375	AAT	869	871	ACC	59;59;59	A;C,T;C	50;49,1;49	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	R135C	NONSYN	403	405	CGT	899	901	TGT	56;56;56	T;G;T	46;49;45	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	K151E	NONSYN	451	453	AAA	947	949	GAA	57;57;57	G;A;A	48;48;47	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	T152N	NONSYN	454	456	ACC	950	952	AAC	58;57;57	A;A;C	49;48;50	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1010	1012	ACA	53;54;54	A;C;A	48;48;48	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1019	1021	GAA	52;52;52	G;A;A	47;47;48	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1022	1024	ACC	52;52;52	A;C,A;C	48;46,1;46	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1028	1030	GTC	52;52;52	G;T;C	43;46;46	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1058	1060	ACG	51;51;51	A;C;G	46;43;45	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1094	1096	AAC	44;44;44	A;A;C	39;39;38	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1154	1156	TTG	42;41;40	T;T;G	39;37;37	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1211	1213	ACC	42;43;43	A;C,A;C	32;36,1;38	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1214	1216	GAC	44;44;45	G;A;C,A	35;31;33,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1223	1225	GCG	49;48;48	G;C;G	37;33;37	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1259	1261	GCT	44;44;44	G,C;C;T,C,G	36,1;33;31,1,1	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	250	folP	858	858	91.61	folP.l15.c17.ctg.1	1801	41.0	1	SNP	p	R230S	1	.	.	688	690	AGC	1184	1186	AGC	42;42;42	A,C;G;C	35,1;37;35	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3837	70.5	1	SNP	p	S91F	0	.	.	271	273	TCC	846	848	TCC	80;80;80	T,C;C;C	63,1;66;69	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3837	70.5	1	SNP	p	D95G	0	.	.	283	285	GAC	858	860	GAC	77;76;76	G;A;C	63;63;62	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	906	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3837	70.5	1	SNP	p	D95N	0	.	.	283	285	GAC	858	860	GAC	77;76;76	G;A;C	63;63;62	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	402	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1535	77.6	1	SNP	p	G45D	1	.	.	133	135	GAC	594	596	GAC	104;104;104	G;A,C;C,A	88;86,1;90,1	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	296	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1406	62.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	910	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3254	83.1	1	SNP	p	D86N	0	.	.	256	258	GAC	721	723	GAC	102;102;102	G;A,C;C	86;81,1;82	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	910	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3254	83.1	1	SNP	p	S87W	0	.	.	259	261	AGT	724	726	AGT	102;102;101	A,C;G;T	79,1;87;86	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	910	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3254	83.1	1	SNP	p	S87R	0	.	.	259	261	AGT	724	726	AGT	102;102;101	A,C;G;T	79,1;87;86	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	910	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3254	83.1	1	SNP	p	S87I	0	.	.	259	261	AGT	724	726	AGT	102;102;101	A,C;G;T	79,1;87;86	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	910	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3254	83.1	1	SNP	p	S88P	0	.	.	262	264	TCC	727	729	TCC	102;102;102	T,G;C,A;C	82,1;84,1;88	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	808	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3133	76.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1756	1758	GGC	103;104;102	G,T;G;C,A	89,1;86;83,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1520	1522	GCA	86;86;86	G;C;A	73;69;72	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1523	1525	ATC	88;88;88	A;T;C	76;71;73	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1535	1537	GTG	90;90;91	G;T,G;G	75;71,1;77	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1535	1537	GTG	90;90;91	G;T,G;G	75;71,1;77	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2039	2041	ACC	65;65;65	A;C;C	54;57;56	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2093	2095	GCG	58;57;57	G,T;C;G	47,1;40;43	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2093	2095	GCG	58;57;57	G,T;C;G	47,1;40;43	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2216	2218	GGC	58;58;58	G,A;G;C	48,1;52;51	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2225	2227	GGC	61;59;58	G;G;C	51;50;51	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	660	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2824	69.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2243	2245	CCG	65;65;64	C;C;G	57;56;53	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1050	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3509	89.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	548	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2252	72.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	724	724	C	62	C	53	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	G38E	NONSYN	112	114	GGA	571	573	GAA	96;96;96	G,A;A;A,C	78,1;80;76,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	601	603	GGA	101;100;100	G;G;A	84;84;84	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	718	720	GCT	93;94;95	G;C;T	78;80;81	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	724	726	AGC	91;92;92	A;G;C	73;81;80	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	816	817	CG	97;97	C;G	83;81	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	819	821	CAG	97;96;96	C;A;G	78;79;80	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	823	825	AAA	96;96;96	A;A;A	78;80;81	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	886	888	GAA	85;85;85	G;A;A	66;69;66	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	910	912	GCA	88;89;87	G,A;C,T;A	71,1;67,1;69	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1093	1095	GAT	91;91;93	G;A;T	82;81;82	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1096	1098	GGT	93;92;90	G;G;T	81;83;81	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1111	1113	ATG	88;88;88	A;T;G	82;77;81	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	0	.	p	.	0	G255fs	FSHIFT	763	763	G	1222	1222	G	87	G	73	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	1	SNP	p	G120K	1	.	.	358	360	AAG	816	818	CGG	97;97;97	C;G;G	83;81;81	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	1	SNP	p	D121N	0	.	.	361	363	GAC	819	822	CGC	97;96;96	C;G;C	78;80;78	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	480	porB1b	1047	1047	97.04	porB1b.l6.c17.ctg.1	1889	73.5	1	SNP	p	A121D	1	.	.	361	363	GAC	819	822	CGC	97;96;96	C;G;C	78;80;78	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	1870	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5412	103.3	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2264	2266	CAT	89;87;87	C,A;A,C;T,G	80,1;80,1;80,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	346	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1469	70.4	1	SNP	p	V57M	1	.	.	169	171	ATG	762	764	ATG	139;139;139	A;T;G	118;118;118	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
